Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $10.45 in the prior trading day, UiPath Inc (NYSE: PATH) closed at $10.21, down -2.30%. In other words, the price has decreased by -$2.30 from its previous closing price. On the day, 16.52 million shares were traded. PATH stock price reached its highest trading level at $10.445 during the session, while it also had its lowest trading level at $10.11.
Ratios:
Our goal is to gain a better understanding of PATH by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.45 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.42. For the most recent quarter (mrq), Quick Ratio is recorded 2.82 and its Current Ratio is at 2.82. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Macquarie Downgraded its Outperform to Neutral on June 03, 2024, whereas the target price for the stock was revised from $29 to $12.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 03 ’25 when Ramani Hitesh sold 12,500 shares for $10.19 per share. The transaction valued at 127,322 led to the insider holds 314,891 shares of the business.
HITESH RAMANI bought 12,500 shares of PATH for $135,250 on Apr 03 ’25. On Feb 25 ’25, another insider, Ramani Hitesh, who serves as the Chief Accounting Officer of the company, sold 12,500 shares for $12.68 each. As a result, the insider received 158,449 and left with 256,921 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PATH now has a Market Capitalization of 5763106304 and an Enterprise Value of 4079041792. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.94 while its Price-to-Book (P/B) ratio in mrq is 3.06. Its current Enterprise Value per Revenue stands at 2.853 whereas that against EBITDA is -33.16.
Stock Price History:
The Beta on a monthly basis for PATH is 0.95, which has changed by -0.47774935 over the last 52 weeks, in comparison to a change of 0.017286062 over the same period for the S&P500. Over the past 52 weeks, PATH has reached a high of $20.95, while it has fallen to a 52-week low of $9.38. The 50-Day Moving Average of the stock is -13.24%, while the 200-Day Moving Average is calculated to be -19.04%.
Shares Statistics:
The stock has traded on average 12.84M shares per day over the past 3-months and 20186220 shares per day over the last 10 days, according to various share statistics. A total of 471.06M shares are outstanding, with a floating share count of 416.13M. Insiders hold about 24.54% of the company’s shares, while institutions hold 52.62% stake in the company. Shares short for PATH as of 1743379200 were 30163274 with a Short Ratio of 2.35, compared to 1740700800 on 33563297. Therefore, it implies a Short% of Shares Outstanding of 30163274 and a Short% of Float of 7.01.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
